ClinicalTrials.Veeva

Menu

Combination of Diclofenac Potassium and Propolis in the Therapy of Oral Aphthosis

A

Al-Azhar University

Status and phase

Completed
Early Phase 1

Conditions

ORAS
Oral Mucositis
Oral Ulcer
Oral Infection

Treatments

Combination Product: Combination of diclofenac potassium and propolis
Other: placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT05413096
oral Aphthosis 650/3607

Details and patient eligibility

About

The combination of diclofenac and propolis could enhance the healing of recurrent aphthous ulcers, instantly relieve symptoms, improve the quality of life, and present a de novo and cost-effective regime help in oral ulcer treatment. This study aimed to evaluate the influence of diclofenac and propolis combination as a gel in the treatment of recurrent oral ulceration

Enrollment

100 patients

Sex

All

Ages

5 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • patients have an oral mucosal ulcer

Exclusion criteria

  • patients allergic to any component of the diclofenac formulation and other NSAIDs

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

100 participants in 2 patient groups, including a placebo group

placebo tube
Placebo Comparator group
Description:
neutral material without any biological effects
Treatment:
Other: placebo
Combination of diclofenac potassium and propolis
Active Comparator group
Description:
active agents combination of diclofenac potassium 3% (10 mg/g, 60 g, EMS) and Propolis 5% gel
Treatment:
Combination Product: Combination of diclofenac potassium and propolis

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems